Completed Access to Information Requests

Follow:

  • RSS
  • Cite

    Cite

    APA

    Open Government - Government of Canada. (2017, December 10). Completed Access to Information Requests. Retrieved from http://open.canada.ca/en/search/ati?f%5B0%5D=ss_ati_organization_en%3AToronto%20Port%20Authority&amp%3Bamp%3Bati%5B0%5D=ss_ati_monthname_en%3ADecember&amp%3Bamp%3Bati%5B1%5D=ss_ati_monthname_en%3ANovember&amp%3Bamp%3Bati%5B2%5D=ss_ati_organization_en%3ACanada-Newfoundland%20and%20Labrador%20Offshore%20Petroleum%20Board&amp%3Bamp%3Bati%5B3%5D=ss_ati_organization_en%3ADepartment%20of%20Finance%20Canada&amp%3Bati%5B0%5D=ss_ati_organization_en%3AExport%20Development%20Canada&ati%5B0%5D=%3ACanada-Newfoundland%20and%20Labrador%20Offshore%20Petroleum%20Board&ati%5B1%5D=%3ACanadian%20Forces%20Morale%20and%20Welfare%20Services&ati%5B2%5D=%3AJacques%20Cartier%20and%20Champlain%20Bridges%20Incorporated&ati%5B3%5D=%3ARCMP%20External%20Review%20Committee&ati%5B4%5D=ati_month_en%3AMay&ati%5B5%5D=ati_month_en%3ANovember&ati%5B6%5D=ati_organization_en%3AFisheries%20and%20Oceans%20Canada&ati%5B7%5D=ati_organization_en%3AHealth%20Canada&ati%5B8%5D=ati_organization_en%3AStatus%20of%20Women%20Canada&search_api_fulltext=&sort_by=year&sort_order=DESC&f%5B0%5D=ss_ati_organization_en%3AToronto%20Port%20Authority&page=5
    MLA

    “Completed Access to Information Requests.” Open Government - Government of Canada, 10 December 2017, http://open.canada.ca/en/search/ati?f%5B0%5D=ss_ati_organization_en%3AToronto%20Port%20Authority&amp%3Bamp%3Bati%5B0%5D=ss_ati_monthname_en%3ADecember&amp%3Bamp%3Bati%5B1%5D=ss_ati_monthname_en%3ANovember&amp%3Bamp%3Bati%5B2%5D=ss_ati_organization_en%3ACanada-Newfoundland%20and%20Labrador%20Offshore%20Petroleum%20Board&amp%3Bamp%3Bati%5B3%5D=ss_ati_organization_en%3ADepartment%20of%20Finance%20Canada&amp%3Bati%5B0%5D=ss_ati_organization_en%3AExport%20Development%20Canada&ati%5B0%5D=%3ACanada-Newfoundland%20and%20Labrador%20Offshore%20Petroleum%20Board&ati%5B1%5D=%3ACanadian%20Forces%20Morale%20and%20Welfare%20Services&ati%5B2%5D=%3AJacques%20Cartier%20and%20Champlain%20Bridges%20Incorporated&ati%5B3%5D=%3ARCMP%20External%20Review%20Committee&ati%5B4%5D=ati_month_en%3AMay&ati%5B5%5D=ati_month_en%3ANovember&ati%5B6%5D=ati_organization_en%3AFisheries%20and%20Oceans%20Canada&ati%5B7%5D=ati_organization_en%3AHealth%20Canada&ati%5B8%5D=ati_organization_en%3AStatus%20of%20Women%20Canada&search_api_fulltext=&sort_by=year&sort_order=DESC&f%5B0%5D=ss_ati_organization_en%3AToronto%20Port%20Authority&page=5
    (Report an issue with citation)
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1095 record(s)

Req # A-2023-000946

List of active legal cases that involve a drug or medical device where Health Canada is named as a defendant.

Organization: Health Canada

3 page(s)
November 2023

Req # A-2023-000969

The full list of the serum ingredients provided by and used in conjunction with AlmaTED a medical device recently approved by Health Canada as as a non-invasive hair loss treatment in Canada.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-000975

All meeting notes, minutes, summaries and briefings regarding the meetings of the Selection Committee that met to review bids for Solicitation Number 6D063-204744, Title: "Request For Standing Offer - Rapid Test Covid-19".

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-000978

Certain information related to the status of this company's file with your agency. Company: Enterprise: Les Entreprises De Réfrigération L.S. inc. (NEQ: 1178471000). 1610 Gallant St., Laval, QC H7L 5B2. 3149 Delaunay St., Laval, QC H7L 5A4

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-000994

The Section 1.0.7 “Note to the Reviewer” (Module 1.0.7) from the generic manufacturer of the Estradiol Abbreviated New Drug Submission (ANDS) which appears on the Generic Submissions Under Review (GSUR) List.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-000997

Details concerning all proceedings, requests or recourse currently active, underway or pending or any balance owing to you by the company 9226-6709 Québec Inc. (NEQ: 1166807389). Address: 515 l'Avenir St., Québec, QC G1E 5E8.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-001044

Obtain details concerning all proceedings, requests or recourse currently active, underway or pending or any balance owing to you by the company. Company: Maison Isabelle inc. (NEQ: 1176226232). 95 Radnor St., Trois-Rivières, QC G8T 2E6.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2020-001112

Adverse Drug Reactions (ADRs). Report numbers: E2B_02074491, E2B_02075650, E2B_02076081, E2B_02076428, E2B_02077572, E2B_02077995, E2B_02078001, E2B_02081073, E2B_02082449, E2B_02084090, E2B_02088710, E2B_02091938, E2B_02094774, E2B_02095027, E2B_02102410, E2B_02104204, E2B_02105075, E2B_02106808, E2B_02107364, E2B_02109368.

Organization: Health Canada

888 page(s)
November 2023

Req # A-2020-001215

Adverse Drug Reactions (ADRs). Report numbers: E2B_02499311, E2B_02499388, E2B_02499863, E2B_02500524, E2B_02501051, E2B_02501996, E2B_02502002, E2B_02502004, E2B_02502019, E2B_02502112, E2B_02502123, E2B_02502174, E2B_02502200, E2B_02502201, E2B_02502211, E2B_02502212, E2B_02502815, E2B_02502994, E2B_02503309, E2B_02503692.

Organization: Health Canada

433 page(s)
November 2023

Req # A-2020-001363

Adverse Drug Reactions (ADRs). Report numbers: E2B_02759984, E2B_02759991, E2B_02759992, E2B_02759993, E2B_02759995, E2B_02759999, E2B_02760000, E2B_02760008, E2B_02760014, E2B_02760016, E2B_02760018, E2B_02760028, E2B_02760052, E2B_02760062, E2B_02760069, E2B_02760080, E2B_02760222, E2B_02760224, E2B_02760227, E2B_02760234.

Organization: Health Canada

329 page(s)
November 2023
Date modified: